{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T07:58:32Z","timestamp":1772006312862,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T00:00:00Z","timestamp":1545004800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jjcc.2018.11.009","type":"journal-article","created":{"date-parts":[[2018,12,24]],"date-time":"2018-12-24T08:44:37Z","timestamp":1545641077000},"page":"386-393","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Comparison of heart rate reduction effect and safety between bisoprolol transdermal patch and bisoprolol fumarate oral formulation in Japanese patients with persistent\/permanent atrial fibrillation (BISONO-AF study)"],"prefix":"10.1016","volume":"73","author":[{"given":"Takeshi","family":"Yamashita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiko","family":"Akita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2018.11.009_bib0080","author":"Inoue"},{"key":"10.1016\/j.jjcc.2018.11.009_bib0085","first-page":"e199","article-title":"2014 AHA\/AACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2018.11.009_bib0090","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/ejcts\/ezw313","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in with EACTS","volume":"50","author":"Kirchhof","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jjcc.2018.11.009_bib0095","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1253\/circj.CJ-08-0608","article-title":"Optimal treatment strategy for patients with paroxysmal atrial fibrillation: J-RHYTHM Study","volume":"73","author":"Ogawa","year":"2009","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2018.11.009_bib0100","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jjcc.2012.12.002","article-title":"Current status of clinical background of patients with atrial fibrillation in a community-based survey: the Fushimi AF Registry","volume":"61","author":"Akao","year":"2013","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2018.11.009_bib0105","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.joa.2016.11.003","article-title":"Current use of direct oral anticoagulants for atrial fibrillation in Japan: Findings from the SAKURA AF Registry","volume":"33","author":"Okumura","year":"2017","journal-title":"J Arrhythm"},{"key":"10.1016\/j.jjcc.2018.11.009_bib0110","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/jch.12208","article-title":"Comparison of efficacy and safety between bisoprolol transdermal patch (TY-0201) and bisoprolol fumarate oral formulation in Japanese patients with grade I or II essential hypertension: randomized, double-blind, placebo-controlled study","volume":"15","author":"Matsuoka","year":"2013","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.jjcc.2018.11.009_bib0115","first-page":"2413","article-title":"A placebo-controlled, randomized, double-blind, dose-finding study of 2mg, 4mg and 8mg bisoprolol transdermal patches (TY-0201) in Japanese patients with grade I-II essential hypertension","volume":"33","author":"Matsuoka","year":"2013","journal-title":"Prog Med"},{"key":"10.1016\/j.jjcc.2018.11.009_bib0120","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jjcc.2017.01.008","article-title":"Assessment of a novel transdermal selective \u03b21-blocker, the bisoprolol patch, for treating frequent premature ventricular contractions in patients without structural heart disease","volume":"70","author":"Shinohara","year":"2017","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2018.11.009_bib0125","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jjcc.2013.02.010","article-title":"Heart rate-reducing effects of bisoprolol in Japanese patients with chronic atrial fibrillation: results of the MAIN-AF study","volume":"62","author":"Yamashita","year":"2013","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2018.11.009_bib0130","doi-asserted-by":"crossref","first-page":"527.e1","DOI":"10.1016\/j.ahj.2008.06.010","article-title":"Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study","volume":"156","author":"Davy","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.jjcc.2018.11.009_bib0135","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1056\/NEJMoa1109867","article-title":"Dronedarone in high-risk permanent atrial fibrillation","volume":"365","author":"Connolly","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2018.11.009_bib0140","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jjcc.2016.05.012","article-title":"Heart rate control by carvedilol in Japanese patients with chronic atrial fibrillation: The AF Carvedilol study","volume":"69","author":"Inoue","year":"2017","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2018.11.009_bib0145","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.amjcard.2010.08.062","article-title":"Comparison of effectiveness of carvedilol versus bisoprolol for prevention of postdischarge atrial fibrillation after coronary artery bypass grafting in patients with heart failure","volume":"107","author":"Marazzi","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2018.11.009_bib0150","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1016\/j.jtcvs.2014.06.036","article-title":"2014 AAST guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures","volume":"148","author":"Frendl","year":"2014","journal-title":"J Thorac Cardiovasc Surg"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508718303368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508718303368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:00:23Z","timestamp":1760274023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0914508718303368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0914508718303368"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2018.11.009","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of heart rate reduction effect and safety between bisoprolol transdermal patch and bisoprolol fumarate oral formulation in Japanese patients with persistent\/permanent atrial fibrillation (BISONO-AF study)","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2018.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd on behalf of Japanese College of Cardiology.","name":"copyright","label":"Copyright"}]}}